Shalaby MR - Search Results

1

Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.

Palladino MA Jr, Patton JS, Figari IS, Shalaby MR. Palladino MA Jr, et al. Among authors: shalaby mr. Ciba Found Symp. 1987;131:21-38. doi: 10.1002/9780470513521.ch3. Ciba Found Symp. 1987. PMID: 3330012 Review.

2

The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.

Shalaby MR, Espevik T, Rice GC, Ammann AJ, Figari IS, Ranges GE, Palladino MA Jr. Shalaby MR, et al. J Immunol. 1988 Jul 15;141(2):499-503. J Immunol. 1988. PMID: 2968403

3

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

Shalaby MR, Palladino MA Jr, Hirabayashi SE, Eessalu TE, Lewis GD, Shepard HM, Aggarwal BB. Shalaby MR, et al. J Leukoc Biol. 1987 Mar;41(3):196-204. doi: 10.1002/jlb.41.3.196. J Leukoc Biol. 1987. PMID: 3031189

4

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.

Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr. Espevik T, et al. Among authors: shalaby mr. J Exp Med. 1987 Aug 1;166(2):571-6. doi: 10.1084/jem.166.2.571. J Exp Med. 1987. PMID: 3110354 Free PMC article.

5

Pharmacokinetics of recombinant murine interferon-gamma and human interferon-alpha A/D(Bgl) administered in concert and their influence on natural killer cell function in mice.

Chen SA, Shalaby MR, Crase DR, Palladino MA Jr, Baughman RA. Chen SA, et al. Among authors: shalaby mr. J Interferon Res. 1988 Oct;8(5):597-608. doi: 10.1089/jir.1988.8.597. J Interferon Res. 1988. PMID: 3148670

6

Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.

Palladino MA Jr, Shalaby MR, Kramer SM, Ferraiolo BL, Baughman RA, Deleo AB, Crase D, Marafino B, Aggarwal BB, Figari IS, et al. Palladino MA Jr, et al. Among authors: shalaby mr. J Immunol. 1987 Jun 1;138(11):4023-32. J Immunol. 1987. PMID: 3295044

7

An overview of the history and biologic properties of tumor necrosis factors.

Shalaby MR, Pennica D, Palladino MA Jr. Shalaby MR, et al. Springer Semin Immunopathol. 1986;9(1):33-7. doi: 10.1007/BF00201903. Springer Semin Immunopathol. 1986. PMID: 3523803 Review. No abstract available.

8

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr. Shalaby MR, et al. J Immunol. 1985 Sep;135(3):2069-73. J Immunol. 1985. PMID: 3926894

9

Towards an immunotherapy for p185HER2 overexpressing tumors.

Carter P, Rodrigues ML, Lewis GD, Figari I, Shalaby MR. Carter P, et al. Among authors: shalaby mr. Adv Exp Med Biol. 1994;353:83-94. doi: 10.1007/978-1-4615-2443-4_9. Adv Exp Med Biol. 1994. PMID: 7985544 No abstract available.

10

In vivo augmentation of natural killer activity by combined treatment with recombinant gamma interferon and interleukin-2.

Shalaby MR, Svedersky LP, McKay PA, Finkle BS, Palladino MA Jr. Shalaby MR, et al. J Interferon Res. 1985 Fall;5(4):571-81. doi: 10.1089/jir.1985.5.571. J Interferon Res. 1985. PMID: 3936881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters